Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diltiazem. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1S known ✓ | Q13698 | 11/20 | 0.98 |
| ▸ | CACNA1F known ✓ | O60840 | 1/20 | 0.98 |
| ▸ | CACNA1D known ✓ | Q01668 | 1/20 | 0.98 |
| ▸ | CACNA1C known ✓ | Q13936 | 1/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.98 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.98 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.98 |
| ▸ | HRH2 | P25021 | 1/20 | 0.98 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.98 |
| ▸ | SCN1A | P35498 | 1/20 | 0.98 |
| ▸ | SCN4A | P35499 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diltiazem SCHEMBL15457 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL551731 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL20394103 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL2365380 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL677721 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL30490635 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL6531617 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL10831293 | 1.00 | CYP3A4 (1.00) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL28098244 | 0.99 | CYP3A4 (0.98) | CYP3A4ABCB11LMNAKCNH2MEN1 | |
| Diltiazem SCHEMBL6253529 | 0.99 | CYP3A4 (0.98) | CYP3A4ABCB11LMNAKCNH2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5834023-A | ENTERIC POLYMERIC MEMBRANE COATED PELLETS | ANDRX PHARMACEUTICALS, INC. (US) | 1998-11-10 | — | — | US | disclosed |
| US-5668134-A | LOMEFLOXACIN HYDROCHLORIDE | G. D. SEARLE & CO. (US) | 1997-09-16 | — | — | US | disclosed |
| US-5567441-A | SUSTAINED RELEASE PELLETS COMPRISING MULTILAYER POLYMERIC MEMBRANE | ANDRX PHARMACEUTICALS INC. (US) | 1996-10-22 | — | — | US | disclosed |